Mitochondria, VDR, taste and the research behind Dr. P. R. Raghavan's nanoemulsion
NANO SOMA® is more than an ordinary supplement. Behind the product is Metadichol®, a patented nanoemulsion of natural policosanols developed by chemist Dr. P. R. Raghavan. The product is linked in the manufacturer's professional material to mitochondria, the cells' energy systems, the vitamin D receptor, nuclear receptors, redox balance and the body's own regulatory processes. Many users report that they experience more energy, clarity or a changed body sensation upon starting, while others notice more gradual or subtle changes. This article explains the background, research, possible biological mechanisms and why NANO SOMA® should be understood as part of a holistic approach to cellular health and normal biological balance.
From the Founder's Corner to a wider understanding
In Founder's Corner 14, Dr. Richard Presser, founder and chairman of MagicDichol®, describes how many new users of NANO SOMA® report a quick experience of increased energy. He particularly points to the mitochondria as a possible part of the explanation. The mitochondria are the cells' energy organelles and play a central role in the conversion of nutrients into ATP, which is the cells' most important energy carrier.
Presser also addresses another interesting phenomenon: taste. Although NANO SOMA® is described in the manufacturer's material as virtually tasteless, some users report bitterness, a coconut-like taste, a soapy taste or an unpleasant/nausea taste at the start. According to the manufacturer, this may be linked to individual conditions in the body, and many people find that the taste decreases over time. This should be understood soberly: Taste is affected by many factors, including oral health, mucous membranes, saliva production, pH, diet, hydration, medications, digestion and individual sensory differences.
For Uno Vita, this article is also an opportunity to raise the perspective. NANO SOMA® is not just about energy or taste. The product is part of a larger professional landscape where cell biology, nanotechnology, mitochondria, membranes, receptors, gene expression and the body's information flow meet.
What is NANO SOMA®?
NANO SOMA® is the trade name of a formulation based on Metadichol®, a nanoemulsion of policosanols. Policosanols are long-chain fatty alcohols that are found naturally in wax fractions from, among other things, sugarcane, rice, wheat and certain other plants. In their traditional form, such lipids are poorly water-soluble. The Metadichol® technology is therefore based on nanoformulation, where the policosanols are emulsified into very small particles so that they are easier to disperse in water-based systems.
This is an important distinction. Regular policosanol supplements and a nanoemulsion of policosanols are not necessarily the same biologically. Nanoformulation can affect particle size, dispersion, contact surface area, stability and bioavailability. The patent literature describes policosanol nanoparticles with an effective average size below approximately 100 nm, and Metadichol® is described in patent material as both a liquid and topical nanoparticle formulation.
NANO SOMA® should nevertheless not be understood as a medicine or as a treatment for illness. The most precise description is that the product is an advanced, nano-formulated support product developed to contribute to the body's normal biological regulation processes.
Dr. P. R. Raghavan and the Metadichol® technology
Dr. P. R. Raghavan, also known as Palayakotai R. Raghavan, is the chemist and scientist behind the Metadichol® technology. He has a background in organic chemistry, pharmaceutical research and nanomedicine, and is the founder of NanoRx Inc. His work has particularly focused on how a nanoemulsion of natural lipid fractions can interact with receptors, membranes, gene expression and the cells' regulatory systems.
Metadichol® is described in Raghavan's work as a broad-acting nano-lipid formulation with possible interactions with the vitamin D receptor and several other nuclear receptors. This has made the technology interesting in research into cell communication, immunological balance, metabolism, redox biology, mitochondrial function, telomerase, Klotho, Yamanaka factors and regenerative biology.
At the same time, it is important to emphasize that much of the research is still early, mechanistic or preclinical. Many publications are led by Raghavan himself or communities closely linked to the development of the technology. This makes the research interesting, but also something that should be interpreted with professional sobriety and the need for independent further validation.
From sugar cane to nuclear receptor modulator
A strong article angle is the journey from natural plant lipids to advanced nuclear receptor biology. Policosanols are often associated with older research on cholesterol and lipid metabolism, but Raghavan's work takes the concept further. In Metadichol®, the policosanol fraction is formulated as a nanoemulsion, and the hypothesis is that this formulation can affect biology more broadly than traditional policosanol supplements.
In the manufacturer's and Raghavan's material, Metadichol® is described as a possible modulator of the vitamin D receptor and other nuclear receptors. Nuclear receptors are proteins that function as transcription factors. They can influence gene expression and thus contribute to the regulation of a number of biological processes, including metabolism, immune response, hormonal signaling, cellular differentiation and homeostasis.
This is an exciting but complex area. Nuclear receptors are not simple on/off switches. The response can vary with cell type, tissue, concentration, signaling environment, nutritional status, hormonal status and the presence of co-activators or co-repressors. Therefore, Metadichol® should be described as a technology that is being investigated for possible receptor and gene regulatory activity, not as a product that "controls" the body in a predictable or guaranteed way.
Mitochondria: The cells' energy systems
Mitochondria are often referred to as the cells' powerhouses. It's a simplification, but a useful one. The mitochondria participate in the conversion of energy from carbohydrates and fatty acids into ATP through, among other things, the citric acid cycle and oxidative phosphorylation. ATP is used in everything from muscle contraction and nerve impulses to membrane transport, repair processes, enzyme activity and cellular communication.
When we talk about energy in the body, it is therefore not just about calories. It is also about how well the cells manage to metabolize nutrients, use oxygen, maintain membrane potential, regulate oxidative stress and communicate with the rest of the organism. Mitochondria are not just little batteries; they are dynamic organelles that respond to stress, aging, inflammatory signals, hormones, sleep, nutrient access and physical activity.
This fits well with Uno Vita's basic view: the body can be understood as an electrical, biochemical and information-carrying system. Cells communicate through chemical signals, electrical gradients, membrane charge, metabolites, light-related processes and frequency patterns. The mitochondria are central to this system because they link nutrition, oxygen, energy and signaling together.
When users of NANO SOMA® report more energy, it is therefore obvious to see the experience in the light of cellular energy turnover and regulation. This does not mean that the product should be referred to as a stimulant or as a treatment for low energy. A more precise formulation is that some users experience increased vitality when the body receives support for normal cellular function and balance.
Why some people experience more energy
Many who start with NANO SOMA® report a quick experience of more energy, clarity or bodily lightness. In Founder's Corner 14, this is described as one of the first things some people notice. Some experience it clearly, others more subtly, and some hardly notice.
This variation is expected. Energy experience is affected by many factors: sleep, stress, nutritional status, fluid balance, physical activity, age, hormones, psychological stress, medication use, digestion and general state of health. Mitochondrial function is only one part of the picture.
NANO SOMA® should therefore not be presented as a product that "gives energy" in the same way as caffeine or stimulants. It is more precise to describe the product as a daily support product for normal cellular regulation, where some users experience increased vitality as part of the body's individual response.
Taste at startup
Some users find that NANO SOMA® has a taste at the start. The most common descriptions are bitterness, coconut-like taste, soapy taste or an unpleasant/nauseating taste. According to the manufacturer, the product itself is intended to be virtually tasteless, and variations in taste experience may therefore be due to individual circumstances.
Taste is influenced by many biological and practical factors. Oral cavity, mucous membranes, saliva production, pH, diet, hydration, medications, digestion, stress and sensory sensitivity can all play a role. For some, the taste experience may diminish with continued use. For some this happens within one to two weeks, while others may experience that it takes longer. If the taste is challenging, the product can be taken with a little water, or you can start carefully and observe the body's response.
In case of persistent discomfort, use should be stopped and qualified healthcare personnel should be contacted.
The vitamin D receptor: A central biological hub
One of the most central topics in Raghavan's research is the vitamin D receptor, often abbreviated VDR. VDR is a nuclear hormone receptor and transcription factor. When active vitamin D, calcitriol, binds to VDR, the receptor can influence gene expression through binding to specific DNA sequences and interaction with other receptors, particularly retinoid X receptor.
Classically, VDR is associated with calcium absorption, mineral metabolism and bone health. In recent immunological and molecular biological research, VDR is also linked to immune cells, epithelial barriers, antimicrobial peptides, inflammatory balance, metabolism and cellular differentiation.
Raghavan describes Metadichol® as a modulator of VDR and several other nuclear receptors. In parts of the material, Metadichol® is referred to as an inverse or protean agonist at VDR, i.e. a ligand that can bind the receptor and give a different functional response than classic active vitamin D. Raghavan also describes interaction with thyroid receptors, aryl hydrocarbon receptor, the ROR family, estrogen-related receptors and several other nuclear receptors.
This is an important but complex point. It should not translate into substantial product claims. The safest formulation is that Metadichol® is investigated for possible interaction with VDR and other receptor and gene regulatory systems, and that this is a central research track behind the technology.
VDR and immunological balance
The vitamin D receptor is interesting because it is involved in the regulation of both innate and adaptive immunity. Many immune cells express VDR, and local activation of vitamin D metabolism has been investigated in macrophages, dendritic cells, T cells, B cells and epithelial cells.
VDR signaling is, among other things, linked to the production of antimicrobial peptides such as cathelicidin/LL-37 and β-defensins. These molecules are part of the body's innate defenses and are important for local barriers and microbial balance. VDR has also been investigated in connection with autophagy, inflammation regulation, interferon-related signals, Treg cells and the balance between pro-inflammatory and regulatory immune responses.
This is biologically relevant to understand why Raghavan and other researchers are concerned with VDR. However, it does not provide grounds for marketing NANO SOMA® as an antiviral product or as a product for the treatment of infections. The correct thing to say is that VDR biology is an important field of research, and that Metadichol® has been investigated as a possible VDR-modulating nanoemulsion.
Outsourced laboratories and CROs
One of the more interesting aspects of Metadichol® research is the use of external laboratories and CROs, i.e. contract research organisations. In the manufacturer's and Raghavan's material, several key analyzes are described as performed by third-party laboratories on a fee-for-service basis. This is highlighted as a measure to reduce internal laboratory bias, because critical analyzes are not performed directly by NanoRx staff.
Among the laboratories mentioned in the material are the Institute for Antiviral Research at Utah State University, Skanda Life Sciences in Bangalore and Virongy Bioscience in Virginia. According to the developer's and manufacturer's material, these must have carried out various types of antiviral testing, pseudovirus assays, qRT-PCR, Western blot, gene expression analyzes and receptor-related analyses. Suppliers and support actors for reagents, primers and assay components are also mentioned.
This is a strength of the research model, but not a definitive proof. Outsourcing to external laboratories can reduce practical and observable internal bias. It can also provide access to specialized expertise, biosafety facilities and standardized analysis platforms that a small player does not have. At the same time, such laboratories are paid contractors. Fee-for-service data is therefore not the same as full independent academic replication, where an external research group itself initiates, finances, carries out and publishes the study.
The most balanced understanding is that the Metadichol® work appears as an inventor-driven and patent-driven nanobiotechnology where a small player tries to build credibility through the strategic use of external laboratories. This gives more weight than pure internal data, but the field still needs independent replication and larger controlled human studies.
Bootstrapped biotech: A small player with a big hypothesis
The story of Metadichol® can be described as bootstrapped biotech: one central innovator, a patented core formulation, a broad biological framework and targeted use of external laboratories to test hypotheses. This is a different model to classic pharmaceutical development, where large companies build extensive in-house research departments and carry out step-by-step clinical programs.
This model has advantages and disadvantages. The advantage is flexibility, lower costs, rapid hypothesis testing and the opportunity to explore many mechanistic tracks. The weakness is that research is easily centered around one inventor, one company and one interpretive framework. When most publications and preprints come from the same environment, independent validation becomes extra important.
For Uno Vita, this is an honest and strong article angle: Metadichol® does not represent established mainstream medicine, but a niche within nanoformulated receptor biology that attempts to build a bridge between natural lipids, VDR, nuclear receptors, mitochondria, redox balance and cell regulation.
What the research examines
The research on Metadichol® can be divided into several main areas. Much of the work is preclinical, mechanistic or based on cell models. There are also open human studies, case reports, animal models, patent data and conceptual articles. Overall, this gives an interesting picture, but not the same strength of evidence as large, independent, randomized and controlled clinical trials.
Antiviral and anti-infective research
A significant part of Raghavan's work concerns Metadichol® as a broad-spectrum biological modulator in models related to viruses and microorganisms. In vitro findings have been reported against several virus models, including SARS-CoV-2-related systems and other enveloped viruses. Possible mechanisms via lipid membranes, VDR-related immune regulation, ACE/TMPRSS2-related pathways and signaling networks linked to inflammation have also been described.
This is interesting from a research point of view, but must be communicated very carefully. In vitro inhibition of viruses in cell culture does not mean that the product treats or prevents infections in humans. Concentrations, cell types, exposure model, bioavailability, immune response and clinical context can be completely different in the body than in a laboratory. In a Norwegian article, this should therefore be referred to as preclinical research on cellular and molecular mechanisms, not as an antiviral product claim.
Vitamin C, redox balance and glutathione
Raghavan has published and presented material in which Metadichol® is linked to vitamin C levels and the influence of genes related to vitamin C metabolism. There is an open human study from 2017 where Metadichol® was examined in connection with vitamin C levels, as well as case descriptions. Effects on glutathione have also been reported in some models.
This is interesting because vitamin C and glutathione are central to the body's redox biology. Vitamin C functions, among other things, as an antioxidant and cofactor in several enzymatic processes, while glutathione is one of the body's most important intracellular antioxidant systems. At the same time, the communication must be precise. For humans, vitamin C is an essential nutrient that must normally be supplied through the diet. It should therefore not be claimed that NANO SOMA® replaces vitamin C from food or supplements. The correct formulation is that Metadichol® has been investigated in studies related to vitamin C and redox-related mechanisms.
Telomerase, Klotho and aging biology
Raghavan's work also mentions Metadichol® in connection with telomerase activity, hTERT expression and Klotho-related signals. Telomerase is an enzyme that can affect telomeres, the protective end structures on chromosomes. Klotho is referred to in the research as an ageing-related protein with significance for mineral metabolism, kidney function, oxidative stress and other regulatory systems.
This is relevant for longevity research, but also an area that requires great sobriety. Telomerase activation is biologically complex and can have different meanings in different cell types. Therefore, one should not write that NANO SOMA® reverses aging or extends life. A safe formulation is that Metadichol® has been investigated in preclinical models linked to genes and signaling pathways that are relevant to aging biology.
Yamanaka factors and cellular reprogramming
One of the most interesting research tracks concerns Yamanaka factors such as OCT4, SOX2, KLF4 and c-Myc. These factors are known from research on induced pluripotent stem cells, where mature cells under controlled laboratory conditions can be reprogrammed to a more stem cell-like state.
Raghavan has described that Metadichol® can influence the expression of such factors in various cell models. If such findings are widely and independently confirmed, it may be relevant for future research into cell regeneration, tissue biology and regenerative medicine. But this is not a basis for claiming that NANO SOMA® regenerates tissue, produces stem cells in the body or treats degenerative conditions. It should be referred to as a research trail, not as a product claim.
Metabolic regulation and inflammation-related signaling pathways
Metadichol® has also been investigated in connection with receptors and signaling pathways that are important for metabolism, inflammation, insulin signaling and lipid biology. Among other things, mechanisms related to GPR120, GLUT4, IRS-related signals and cytokine networks are discussed. In animal models and cell models, the influence of oxidative stress, glutathione, inflammatory markers and certain metabolic parameters is also described.
This may be relevant to understand why the product is referred to as broad-acting in the manufacturer's material. At the same time, it should not translate into specific claims about diabetes, blood pressure, autoimmune conditions, infections, cancer, kidney disease or other diagnoses. Consumer-directed language must adhere to the support of normal function, balance, cellular communication and general vitality.
Skin and topical use
NANO SOMA® is also available as a topical gel and skin cream. The manufacturer describes these as products for skin care, soothing support and normal skin balance. In a cosmetic context, one can refer to the skin's moisture, appearance, glow, elasticity and care. On the other hand, claims about wound healing, infections, skin diseases or treatment of specific skin conditions should be avoided, unless the product is regulatory approved for this.
Clinical signals and the need for larger studies
There are small open human studies, case reports and pilot-related data in the Metadichol® literature. Pilot work and preclinical results in infection-related models are also discussed. Such data can be interesting as early signals, but they do not provide the same strength of evidence as large, independent, randomized, placebo-controlled studies.
A responsible understanding is therefore that Metadichol® has an exciting research basis, but that the clinical evidence is still early. Large independent studies are needed to confirm broad effects in humans, map optimal use, identify responder profiles, assess interactions and clarify long-term effects.
Safety and regulatory sobriety
The manufacturer emphasizes low toxicity in preclinical safety data, and policosanols are of natural origin. However, this does not mean that all people should use the product uncritically. Nanoformulations can have different biological properties than traditional raw materials, and people with illness, medication use, pregnancy, breastfeeding or special health conditions should always consult a qualified healthcare professional before use.
In Norway and the EU, product reviews must be sober. It is not permitted to market dietary supplements as treatment, prevention or cure of disease. Claims about viruses, tuberculosis, cancer, diabetes, blood pressure, autoimmune diseases, kidney disease, skin diseases or other diagnoses must not be used as product claims. Research can be referred to as informative, but must be clearly distinguished from marketing and practical use.
How should NANO SOMA® be understood in practice?
NANO SOMA® should be understood as a daily support product for people interested in cellular health, energy, normal biological balance and integrative self-care. The product fits best into a holistic lifestyle with nutritious food, good sleep, daylight, movement, stress management, hydration and conscious support for the body's regulatory systems.
Some will notice quick energy or clarity. Some will notice gradual changes. Some will notice little. Some may experience a taste at first. All of these responses are possible, and none of them should be over-interpreted. The body is individual, and good health is rarely built from one product alone.
A holistic understanding of energy
Energy isn't just about feeling awake. It is about the cells' ability to create, store, use and regulate energy. It is about mitochondria, oxygen, nutrients, membrane potential, redox balance, signaling substances, hormones, circadian rhythm and nervous system. It is also about the flow of information between cells, tissues and organs.
In this perspective, NANO SOMA® becomes interesting because it is not presented as a classic stimulant product, but as a nanoformulated lipid technology that is being investigated for possible interactions with the body's own regulatory systems. This makes the product relevant for people who are concerned with cell health, energy metabolism, integrative health and a modern understanding of the body as an electrical, biochemical and information-carrying system.
Summary
NANO SOMA® and Metadichol® represent an interesting meeting point between natural lipids, nanotechnology, mitochondria, the vitamin D receptor, nuclear receptors, redox balance and the cells' information flow. The product was developed by Dr. P. R. Raghavan and is based on a patented nanoemulsion of policosanols. In the manufacturer's and Raghavan's material, the technology is linked to several areas of research, including VDR modulation, mitochondrial energy metabolism, vitamin C and glutathione-related mechanisms, telomerase, Klotho, Yamanaka factors and immunological regulation.
Many users report increased energy, clarity or a changed body sensation upon start-up. Some people also experience a taste at the start. Such experiences are individual and should not be interpreted as guaranteed effects.
The research around Metadichol® is exciting, but still characterized by preclinical models, small open studies, case descriptions, patent data and publications closely linked to the developer. The use of outsourced laboratories and CROs strengthens the data base compared to purely in-house analyses, but does not replace the need for independent replication and larger controlled human studies.
The best way to present NANO SOMA® is therefore as an advanced, research-based support product in cellular health and integrative lifestyle – not as a treatment for disease. For Uno Vita, the product fits into a holistic understanding of the body as an electrical, biochemical and information-carrying system, where energy, balance and regulation begin in the cells.
Disclaimer
This article is intended for general information only and should not be construed as medical advice. NANO SOMA® is not intended to diagnose, treat, cure or prevent disease. The product should be used in line with the label's recommendations. In the event of illness, symptoms, pregnancy, breastfeeding, use of medication or medical treatment, a doctor or other qualified healthcare professional should be contacted before use. Individual experiences may vary.
Freedom of expression and professional communication
Uno Vita conveys knowledge about integrative health, nutrition, technology and the body's natural regulatory systems based on freedom of expression, scientific curiosity and the right to share professional information. The information is not intended as medical claims, but as knowledge sharing for readers who want to understand the body better and make informed choices in dialogue with qualified healthcare personnel.
Scientific and professional references
- Cooper, G. M. The Cell: A Molecular Approach. 2nd edition. NCBI Bookshelf. Chapter: Mitochondria.
- Alberts, B. et al. Molecular Biology of the Cell. Relevant chapters on mitochondria, ATP, oxidative phosphorylation and nuclear signaling.
- NCBI Gene. VDR vitamin D receptor, Homo sapiens. Gene ID: 7421.
- Evans, R. M. & Mangelsdorf, D. J. Nuclear Receptors, RXR, and the Big Bang. Cell. 2014.
- Gronemeyer, H., Gustafsson, J. Å. & Laudet, V. Principles for modulation of the nuclear receptor superfamily. Nature Reviews Drug Discovery. 2004.
- US8722093B2. Policosanol nanoparticles. Inventor: Palayakotai R. Raghavan. Assignee: NanoRx Inc.
- US9034383B2. Policosanol nanoparticles. Inventor: Palayakotai R. Raghavan. Assignee: NanoRx Inc.
- US9006292B2. Metadichol® liquid and gel nanoparticle formulations. Inventor: Palayakotai R. Raghavan. Assignee: NanoRx Inc.
- Raghavan, P.R. Metadichol® and Vitamin C Increase In Vivo, an Open-Label Study. Vitamins & Minerals. 2017.
- Raghavan, P.R. Metadichol® Induced High Levels of Vitamin C: Case Studies. 2017.
- Raghavan, P.R. Metadichol®: A Novel Nanolipid Formulation That Inhibits SARS-CoV-2. 2022.
- Raghavan, P. R. The Quest for Immortality: Introducing Metadichol® as a Novel Telomerase Activator. 2019.
- Raghavan, P. R. Metadichol® and ROR Gamma-related mechanistic research. 2017.
- Raghavan, P. R. Metadichol® and AHR/NRF2-related mechanistic research. 2017.
- Raghavan, P.R. Metadichol® and thyroid receptor-related research. 2019.
- Raghavan, P. R. Metadichol® and Klotho-related research. 2018–2023.
- Raghavan, P. R. Metadichol®, GPR120 and insulin-resistance-related gene expression research. 2017.
- Raghavan, P. R. Metadichol® and Yamanaka reprogramming factors in somatic and cancer cell models. Medical Research Archives. 2024.
- MagicDichol®. Founder's Corner Edition 14: Energy, mitochondria and NANO SOMA®.
- MagicDichol®. Product and science pages for NANO SOMA® Liquid, NANO SOMA® Topical Gel and NANO SOMA® Skin Cream.
- Research Outreach. Overview article on Metadichol® and Dr. P. R. Raghavan's research. 2023.
